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. The cytoplasmic COOH-terminal region College of Physicians and Surgeons contains an EF-hand domain. There is 25%-30% identity Columbia University and 45%-50% similarity between polycystin-2 and both New York, New York 10032
an ‫-054ف‬amino acid portion of polycystin-1 or ‫-072ف‬ residue region of the family of voltage-activated calcium channel ␣ 1 subunits. A third ADPKD gene has been impliSummary cated as a rare cause of the disease but has not been mapped (Daoust et al., 1995) . Germline mutations in PKD2 cause autosomal domi-PKD1 and PKD2 are widely expressed in fetal and nant polycystic kidney disease. We have introduced a adult tissues (Mochizuki et al., 1996; . mutant exon 1 in tandem with the wild-type exon 1 at
The immunohistochemical staining profile of PKD2 has the mouse Pkd2 locus. This is an unstable allele that not been reported. PKD1 is expressed in tubular epitheundergoes somatic inactivation by intragenic homololial cells (Griffin et al., 1996; Palsson et al., 1996 ; Peters gous recombination to produce a true null allele. Mice et al., 1996; ; Ibraghimov-Beskrovnaya heterozygous and homozygous for this mutation, as et al., 1997) , and its expression is developmentally reguwell as Pkd ؉/Ϫ mice, develop polycystic kidney and lated (Geng et al., 1996; van Adelsberg et al., 1997) .
liver lesions that are indistinguishable from the human
Recently, a mouse model deleting exon 34 of Pkd1 has phenotype. In all cases, renal cysts arise from renal confirmed a role for Pkd1 during development (Lu et al. , tubular cells that lose the capacity to produce Pkd2 1997) . In ADPKD, all nephron segments can give rise to protein. Somatic loss of Pkd2 expression is both cysts; however, the process is focal, with only a small necessary and sufficient for renal cyst formation in fraction of nephrons involved in cyst formation (Gabow ADPKD, suggesting that PKD2 occurs by a cellular and Grantham, 1997) . Cyst-lining cells have been charrecessive mechanism.
acterized as being in a less-well-differentiated state than the tubular epithelial cells from which they are derived (Calvet, 1993) .
Introduction
It has been hypothesized that polycystin-1 acts as a receptor for either cell-matrix or cell-cell interactions Autosomal dominant polycystic kidney disease (ADPKD) (American PKD1 Consortium, 1995; Hughes et al., 1995 ; consists of at least three genetically distinct disorders International Polycystic Kidney Disease Consortium, characterized by bilateral renal tubular cyst formation 1995). The observation that patients with either PKD1 and progressive enlargement (Gabow, 1993) . ADPKD or PKD2 share virtually identical clinical phenotypes results in renal failure in ‫%05ف‬ of affected individuals by the age of 60. It affects between 1 in 600 and 1 in (Parfrey et al., 1990; Ravine et al., 1992) prompted spec-1000 live births in all ethnic groups worldwide. Hepatic ulation that PKD1 and PKD2 are components of the cysts arising from biliary epithelium are common and same signaling pathway. Recent studies have shown increase with age, female sex, and number of pregnanthat PKD1 and PKD2 interact directly via their respective cies (Everson, 1993) . Additional extrarenal manifestacytoplasmic COOH-terminal domains ; tions include cysts in the pancreas and spleen, cardiac Tsiokas et al., 1997) . Germline mutations in both genes valvular abnormalities, and intracranial saccular aneuappear to inactivate the mutant allele, and no clustering rysms.
of mutations has been observed in either gene (Peral et PKD1 , the gene mutated in 85% of ADPKD patients al., 1996; Roelfsema et al., 1997; Veldhuisen et al., 1997) . (Peters and Sandkuijl, 1992) , is located in 16p13.3 and Recent studies of cyst-lining epithelial cells have demencodes a 4303-amino acid integral membrane glycoonstrated loss of heterozygosity (LOH) at the wild-type protein, polycystin-1 (European Polycystic Kidney Dis-PKD1 allele (Qian et al., 1996; Brasier and Henske, 1997 ) ease Consortium, 1994; American PKD1 Consortium, and have lead to the hypothesis that cyst formation in PKD1 is the result of a clonal expansion of individual cells acquiring second hits in the normal PKD1 allele 6 To whom correspondence should be addressed. 7 These authors contributed equally to this work.
(Qian and Germino, 1997). No data are currently available on the mechanism of Results cyst formation in PKD2. To investigate the role of PKD2 in the pathogenesis of ADPKD, we introduced targeted
Generation of Pkd2 Mutant Mice
The mouse Pkd2 cDNA is predicted to encode an intemutations into the mouse homolog, Pkd2. The resulting animal models faithfully recapitulate the human disease gral membrane protein with 91% sequence identity and 98% similarity to human polycystin-2 . and demonstrate that cyst formation occurs through a cellular recessive mechanism.
We isolated genomic clones containing the Pkd2 gene Northern blot analysis of total RNA from kidneys of Pkd2 WS25/WS25 mice revealed presence of wild-type Pkd2 mRNA at reduced levels ( Figure 1C) . No stable mRNA species other than the wild-type 5.2 kb message were identified. To determine if these mice produced stable Pkd2 protein, we performed Western blot analysis with polyclonal antisera, YCB9 and YCC2, directed against cytoplasmic NH 2 -or COOH-terminal regions of polycystin-2, respectively. Both antisera are made against epitopes downstream of the neo r insertion, although the immunogen for YCB9 included a portion of exon 1. Each antiserum detected a single immunoreactive band migrating at 110 kDa, identical to the wild-type protein (Figure 2 ). Heterozygous and homozygous mutant mice had reduced levels of Pkd2 protein, and the expression of Pkd2 varied widely among Pkd2 WS25/WS25 mice Pkd2 locus in an effort to understand these findings.
of protein (lanes 7 and 8) were among the four most severely affected with kidney cysts. Mice in lanes 6 and 9 had mild cystic disease.
Southern hybridization of ApaI-digested genomic DNA
The control for protein loading utilized Coomassie brilliant blue stainusing probe 1 ( Figure 1A) expected 3Ј integration event ( Figure 1B ). However, hybridization of the same digest with the internal probe 3 revealed a doublet at 12 and ‫5.21ف‬ kb ( Figure 1B) , and deduced the exon-intron organization of Pkd2 (Wu suggesting the existence of an additional copy of the et al., unpublished data). Pkd2 has an equal number of probe 3 target sequence. The wild-type 4.0 kb PstI and similarly sized exons as its human counterpart (Hayashi 1.3 kb PstI/NotI double-digest fragments were present et al., 1997). A 7.5 kb EcoRI fragment containing the in DNA from Pkd2 WS25/WS25 mice hybridized with probe 3 first coding exon of Pkd2 was subcloned into pUC19 ( Figure 1D ), indicating the continued presence of wild- (Figure 1 ). Exon 1 was disrupted by introduction of a type exon 1. The PstI fragment representing the 5Ј upselectable neo r cassette in the same transcriptional oristream portion of the disrupted exon 1 * migrated at 2.5 entation as Pkd2 into the unique NotI site at codon 59 kb ( Figure 1D ) instead of the expected 1.8 kb ( Figure 1A ( Figure 1A [ii]), introducing an in-frame stop codon nine
[iii]). Pkd2 ϩ/WS25 mice showed a greater relative intensity codons downstream of the 5Ј cloning junction. The tarof the 4.0 kb PstI fragment relative compared to the 2.5 geting vector Pkd2x1neo contained ‫5.7ف‬ kb of homolokb mutant allele, a finding consistent with increased gous sequence extending 0.6 kb 5Ј and 6.9 kb 3Ј to the dosage of the wild-type exon 1 relative to the mutant neo r cassette. exon. Taken together, these data confirm the anomalous Pkd2x1neo was introduced into WW6 ES cells (Ioffe nature of the 5Ј integration event and show that the et al., 1995) by electroporation, and 196 colonies resistargeting vector integrated into the first intron of Pkd2 tant to G418 were selected. Sequencing of PCR prodwithout replacing the wild-type exon 1 ( Figure 1A [iv]) ucts formed by primers outside the 5Ј end of Pkd2x1neo (Hasty et al., 1991 characterized first. mice (aged 4, 5, 8, 9, 10, 11, and 14 weeks) (Figure 3 ). In Pkd2 ϩ/WS25 , renal cysts were unilateral and microscopic. There were 2 to 5 discrete tubular cysts clustered in the Analysis of the WS25 Pkd2 Mutant Allele WS25 produced ten chimeric mice, of which five, exhibcortex and/or outer medulla per kidney (Figures 3A and 3B) . Early microcysts sometimes displayed mild epitheiting 70%-90% chimerism, were mated. Of 149 agouti F1 progeny, 69 (46%) were heterozygous for the WS25 lial hyperplasia ( Figure 3C ). A more severe but considerably heterogenous renal mutation (Pkd2
). Pkd2 ϩ/WS25 mice derived from different chimeras were intercrossed and the F2 progeny phenotype was identified in Pkd2 WS25/WS25 mice. Cysts were bilateral in 8 of 9 mice, and affected kidneys were were genotyped ( Figure 1B ): 23% were Pkd2 ϩ/ϩ , 57% were Pkd2 ϩ/WS25 , and 20% were Pkd2 WS25/WS25 (n ϭ 282), mildly enlarged with grossly identifiable translucent macrocysts 0.5 to 4.0 mm in diameter. The bisected kidney suggesting no deleterious effect of the Pkd2 targeting event on early survival.
surface area occupied by cysts ranged from 5% to 90% ( Figures 3D and 3E ). Mice with the lowest expression of failure and in 75% of patients over the age of 60 (Everson, 1993) . Histological analysis on livers from 31 Pkd2 (Figure 2 , lanes 7 and 8) were the ones most severely affected with renal cysts. In mice with milder phePkd2 ϩ/WS25 mice and 14 Pkd2 WS25/WS25 mice identified hepatic cysts in 3 Pkd2 WS25/WS25 mice aged 4, 9, and 10 notypic abnormalities, cysts occurred in the inner and outer stripe of the outer medulla as well as the cortex weeks. Two of these mice were again the ones with the lowest levels of Pkd2 ( Figure 2 , lanes 7 and 8). One and were often clustered ( Figure 3B ). In kidneys with severe disease, cysts were also identified in the inner liver contained at least ten individual cysts ranging from microcysts to 1 mm in size. Another contained a single medulla ( Figure 3F ). Glomerular cysts were rare ( Figure  3G ). Tubular cysts were lined by a monolayer of epitheseptated 4 mm macrocyst ( Figure 3K ). Cysts were lined by a monolayer of cuboidal or flattened biliary epithelium ranging from cuboidal to hobnail or flattened. Most cysts lacked a recognizable brush border, suggesting lium. Most cysts were rounded ( Figures 3L and 3M ), whereas others displayed more convoluted, angulated, origin from the distal nephron ( Figures 3H and 3I ). Loose proteinaceous casts were identified in cysts (Figures or branching contours ( Figure 3N ). Pkd2 WS25/WS25 mice exhibited a major extrarenal feature of ADPKD: liver 3E, 3H, and 3J). Larger cysts were often septated ( Figure  3G ) and surrounded by atrophic renal parenchyma with cysts arising from bile duct epithelium. interstitial fibrosis and mild inflammation ( Figure 3J ). The noncystic renal parenchyma appeared normally deSegments of Origin of Renal Tubular Cysts veloped.
Using nephron segment-specific lectins Lotus tetragonolobus (proximal tubule) and Dolichos biflorus (collecting tubule) (Laitinen et al., 1987) and antibody to WS25 Pkd2 Mutant Mice Develop Liver Cysts The most common extrarenal manifestation of ADPKD Tamm-Horsfall protein (distal tubule) (Hoyer and Seiler, 1979) , the majority of renal cysts were found to involve is liver cysts, which occur in 50% of patients with renal the more distal portions of the nephron (Figure 4) . A from the basal membrane into the basal cytoplasm (Figure 5C) . A more narrow and slightly less intense band mean 40% of cysts were of collecting tubular origin, 42% distal tubular origin, and 5% proximal tubular origin.
of basal cytoplasmic and membrane staining was identified in the cortical and medullary collecting tubules. Thirteen percent of cysts failed to stain with any marker. The latter included glomerular cysts and some extremely Much weaker and more delicate staining outlined the basal cell membrane of the proximal tubules ( Figure 5D ). large macrocysts. Some of the larger cysts displayed skip areas with discontinuous lectin staining over short
No staining was observed in the glomerular tuft, visceral or parietal epithelium, thin limbs of Henle, interstitium, segments of the cyst wall ( Figures 4D and 4F ). These findings are consistent with previously reported data or blood vessels. This pattern of expression is similar to that observed in human kidneys (Y. Cai et al., unpubfor human ADPKD indicating that cysts may affect all segments of the neprhon. However, in these mice there lished data). Kidneys of Pkd2 ϩ/WS25 mice with normal renal phenois a clear predilection for cysts to arise from the more distal nephron segments, a finding that has not been type displayed an intensity and distribution of Pkd2 immunostaining indistinguishable from wild-type kidneys. conclusively investigated in human ADPKD.
Heterozygote kidneys with a cystic phenotype displayed complete absence of immunoreactivity for polycystin-2 Loss of Polycystin-2 Expression Leads to Cyst Formation in renal cysts, with retention of normal staining in adjacent noncystic tubules ( Figure 5E ). Immunostains for Pkd2 in wild-type mouse kidney using the YCC2 antiserum revealed a highly segment-specific Cysts in Pkd2 WS25/WS25 kidneys showed localized complete absence of Pkd2 immunostaining throughout the epithelial staining pattern (Figures 5A and 5B) . Strongest reactivity for Pkd2 was observed in the distal convoluted epithelium of every renal cyst, irrespective of cyst size or nephron segment of origin ( Figures 5F-5H ). The segtubules and medullary thick ascending limbs of Henle. In both segments, staining was basolateral, extending ment-specific staining studies demonstrate that cysts in Pkd2 mutant mice preferentially arise from the regions of the nephron that express Pkd2 most highly. Yet, the cells lining these cysts uniformly do not express Pkd2, while it is expressed in the surrounding noncystic regions. This lack of polycystin-2 expression is not a result of profound de-differentiation, since staining of serial sections shows that cystic epithelia still express segment-specific markers. We conclude that a subset of tubular epithelial cells lose the capacity to express polycystin-2, and these cells give rise to cysts in the WS25 mutant mouse line.
Intragenic Recombination Inactivating Both Pkd2 Alleles Results in Cyst Formation
The complete loss of Pkd2 expression in cyst-lining cells suggests that a cellular recessive mechanism is responsible for cyst formation in the WS25 mutant line. It is necessary to reconcile the nature of the WS25 mutation, which allows continued expression of Pkd2, with the observed loss of Pkd2 expression in cyst-lining cells. Several lines of experimental evidence suggest a likely explanation. Two Pkd2 WS25/WS25 mice with pathologically very severe cystic disease and extremely low levels of Pkd2 (Figure 2 , lanes 7 and 8) have a novel 1.8 kb PstI restriction fragment when probed with the exon 1-specific probe 3 ( Figure 6A ). This 1.8 kb PstI fragment was not present in the genomic DNA of the parents of either mouse nor did any of their littermates share this allele. The occurrence of a novel 5.0 kb HindIII allele, detected by the same probe (data not shown), in mice with the 1.8 kb PstI fragment suggests that these novel restriction fragments are the result of a genomic rearrangement.
To test the hypothesis that genomic rearrangement results in loss of Pkd2 expression and gives rise to cyst formation, we prospectively screened 61 Pkd2 WS25/WS25 and 102 Pkd2 ϩ/WS25 mice for presence of the 1.8 kb PstI fragment. Two additional Pkd2 WS25/WS25 mice had this allele and were affected with grossly visible cysts ( Figure  6B ). None inherited this allele from their parents. The 1.8 kb PstI allele was not observed in the five other homozygous mice with cysts. No Pkd2 ϩ/WS25 mice had this restriction fragment.
Based on the the genomic structure of the WS25 allele, we suggest that genomic rearrangement is mediated by intragenic homologous recombination between tandemly repeated portions of the wild-type and mutant by unequal sister chromatid exchange. Arrows represent location digests from Pkd2 WS25/WS25 mice, with lane 1 having the additional of PCR primers producing the 832 bp product (PCR) in the null 1.8 kb allele. This mouse had very severe, grossly visible cystic allele after recombination. The asterisks mark enzyme sites that are involvement of both kidneys.
brought together by recombination to form the novel 1.8 kb PstI (C) Schematic representation of intragenic homologous recombinaand 5.0 kb HindIII fragments. tion in the WS25 allele. Recombination r1 produces a null allele (D) Southern hybridization of PCR products using an internal probe. (shown), while the recombination r2 produces a wild-type allele.
The signal corresponds to the 832 bp product formed by intragenic Shown on a single strand for illustration, this process could occur recombination on the WS25 allele.
PstI and HindIII restriction pattern was the one expected Pkd2 WS25/WS25 mice. The requirement for a naturally occurring somatic mutation in the normal allele would exif the initial gene targeting event had resulted in replaceplain the very low rate of cyst formation observed in the ment of wild-type exon 1 ( Figure 1A [iii] ). Thus, the allele heterozygous WS25 mice. resulting from intragenic recombination 5Ј to the neo r These findings would suggest that mice heterozygous cassette is predicted to produce a true null allele defifor a true null allele would develop cystic kidneys at a cient in active and immunoreactive polycystin-2.
higher rate than WS25 heterozygotes. Compound cisIf the intragenic recombination event occurs 3Ј to the heterozygote mice with one true null allele for Pkd2 and neo r cassette, it would be predicted to form the wild-type one WS25 allele would reliably and reproducibly develop allele ( Figure 6C ). The latter event would be predicted to ADPKD and could serve as a practical model of the be more frequent than the 5Ј recombination since the human disease. region of homology 3Ј of the neo r cassette is much larger. We next analyzed the mouse line derived from the Twenty-five mice were Pkd2 WS25/WS25 and five mice were WS183 ES cell clone to determine if this line had underPkd2 ϩ/WS25 , demonstrating the occurrence of the pregone the expected exon 1 replacement and given rise dicted genomic rearrangement reverting to the wildto a true null allele ( Figure 1A [iii]). WS183 produced six type allele. chimeric mice, of which three were mated. Of the 36 Southern blot evidence of genomic rearrangement reagouti F1 progeny, 14 (38%) were found to be heterozyquires substantial dosage of the recombined allele in gous for the WS183 mutation (Pkd2 . No ApaI 12 kb doublet was biopsy and tissue-specific genomic DNA by PCR with detected with probe 3 in WS183 mice. Probe 3 hybridthe primer pairs used in the original ES cell screening ized to the wild-type 4.0 kb band and the expected 1.8 ( Figure 6C ). We formally excluded the existence of a kb band on PstI-digested genomic DNA without eviduplication of the region upstream of exon 1 at the 5Ј dence of the aberrant 2.5 kb fragment seen in WS25 end of the targeting vector integration site by hybridizing ( Figure 7A ). Western blots of total protein extracted from a 195 bp genomic PCR product to PstI-digested genoembryos showed reduced levels of protein in Pkd2 ϩ/Ϫ mic DNA from mutant animals. This 195 bp probe conand complete absence of Pkd2 protein in Pkd2 Ϫ/Ϫ mice tained both forward PCR primers used in the nested ( Figure 7B ). PCR screen and hybridized only to the wild-type 4.0 kb Detailed histological examination of both kidneys PstI fragment, confirming that the forward primers were from 29 Pkd2 ϩ/Ϫ mice (age range 9-17 weeks) showed single copy and located upstream of the wild-type exon the presence of 1 to 5 unilateral renal cysts in six mice 1 ( Figure 6C ). The expected 832 bp nested PCR product (21%) ( Figure 7C ). In addition, two Pkd2 ϩ/Ϫ mice had 1 to can only be amplified from WS25 genomic DNA if intra-2 liver cysts and a third animal had bile duct proliferation similar to that seen in ADPKD (not shown). Immunostaingenic homologous recombination has occurred in at ing of the cysts in five kidneys showed absence of Pkd2 least a subset of cells. Amplification of genomic DNA expression in the cyst-lining cells ( Figure 7D) Figure 6D ). The identity of quency of occurrence and spectrum of organ system this product with the expected product was confirmed involvement between Pkd2 ϩ/WS25 and Pkd2 WS25/WS25 aniby direct sequencing. In retrospect, our original PCR mals. These mice likely represent a true model of human screen of the WS25 ES cell line was positive because a ADPKD. subset of the ES cells had undergone this recombination during expansion of the clones. However, the cells that transmitted through the germline from our chimeric mice Severe ADPKD in Pkd2 WS25/Ϫ Mice had a WS25 allele that had not undergone this reWe intercrossed Pkd2 ϩ/Ϫ mice with either Pkd2 . The occurrence of conversion. The requirement for doubly affected cells Pkd2 ϩ/ϩ in the latter cross and the suggestion of a skew to initiate cyst formation would explain the variability in in the former is the result of rearrangement in WS25 to form the wild-type allele. the occurrence and severity of cysts noted in these 
Six Pkd2
WS25/Ϫ mice sacrificed at 10-11 weeks all had phenotype as predicted by our model. With one null allele, any tubular cell undergoing the 5Ј rearrangement bilateral renal cysts involving 20%-75% (mean, 45%) of the cut surface area of each kidney ( Figure 7E ). All six on the WS25 allele becomes deficient in Pkd2 and goes on to form cysts. mice had 1 to 10 liver cysts and 3 of 6 also had bile duct proliferation. Cyst-lining cells in all 12 kidneys were uniformly negative for immunostaining with the YCC2 Discussion antiserum ( Figure 7F ). Figure 7G summarizes the severity in the ADPKD phenotype associated with the various
We have produced four animal models of PKD2 that recapitulate the human ADPKD phenotype. All of these mutant genotypes. Pkd2 WS25/Ϫ mice have the most severe models show continued production of Pkd2 and are has to occur on the normal Pkd2 allele. Cyst formation is more common in Pkd2 ϩ/Ϫ than Pkd2 ϩ/WS25 mice since therefore functionally analogous to the heterozygous human disease state. Kidneys form normally in the muthe latter must undergo rearrangement of the WS25 allele as well. Since mutations of the normal allele may tant mice, and cysts arise as focal outpouchings from the walls of normal, mature tubules. The cysts are lined involve missense changes, the absence of Pkd2 immunostaining in cyst walls of heterozygous mice may by an attenuated, flattened epithelium, some with hyperplastic features. Initially, cyst lining cells retain a difbe a consequence of the relatively small total number of cysts examined, the use of a COOH-terminal antiferentiated cell type but subsequently show loss of nephron segment-specific surface markers. In the liver, body, or instability of the mutant mRNA or translation products. biliary epithelia give rise to cysts. Fibrosis with mild inflammation is seen surrounding renal and hepatic LOH for PKD1 has been observed in cyst-lining cells in human ADPKD (Qian et al., 1996 ; Brasier and Henske, cysts. The histologic features of the renal cystic disease in mutant mice are virtually identical to those described 1997; . The causal nature of this finding has been challenged (Harris and Watson, for human ADPKD (Evan and McAteer, 1992; Gabow and Grantham, 1997) . These results show that mutation 1997; Ong and Harris, 1997) . It has been proposed that PKD2 results from clonal expansion of compound transin the mouse homolog of PKD2 can cause renal cystic disease and provide functional proof that PKD2 mutaheterozygote cells with a germline inactivating mutation in PKD2 and a somatic mutation in PKD1 (Qian et al., tions are pathogenic in ADPKD.
1996; Qian and Germino, 1997). Our current data provide evidence for an alternative hypothesis. Cyst formation A Cellular Recessive Mechanism in PKD2 requires inactivation of both Pkd2 alleles. We for Cyst Formation have not observed any cysts in our models that express Cysts arise from cells that lose the ability to express Pkd2 protein as would be expected in a cyst arising by functional Pkd2. There is loss of polycystin-2 expression a compound trans-heterozygote mechanism. In heteroin all renal cyst lining cells. The majority of these cells zygous mice, absence of Pkd2 immunostaining in cysts are derived from nephron segments that express Pkd2
indicates that somatic mutations have affected the norhighly, so this finding is not the result of limiting detecmal Pkd2 allele. We suggest that cysts in human PKD2 tion of immunoreactivity. The severity of cyst formation also arise as a consequence of two hits at the PKD2 is enhanced by the presence of the WS25 mutation. This locus. With evidence for homozygous LOH at Pkd2 in allele is unstable and undergoes somatic conversion to our mice and without direct evidence for a compound a null (or wild-type) allele in vivo. The propensity for this trans-heterozgote mechanism, it is possible that the sorearrangement is a direct result of the structure of the matic mutation rates for the respective regions of the WS25 Pkd2 mutation. WS25 contains wild-type and muhuman genome are sufficient to account for the obtant exon 1 and flanking intronic sequences in tandem, served rates of cyst formation in PKD1 and PKD2 (Qian allowing for intragenic homologous recombination by and Germino, 1997). PKD2 families are less common either unequal sister chromatid exchange or intrastrand than PKD1 because mutations at PKD2 occur less frerecombination (Lifton et al., 1992; Ellis and German, quently in the population. The rate of cyst formation in 1996; Chen et al., 1997) . When both alleles in a tubular PKD2 is slower because the rate of somatic mutation epithelial cell become null for Pkd2, that cell expands at this locus is less than at PKD1. An assessment of the clonally and a cyst ensues (Qian et al., 1996) . contribution to cyst formation of LOH at PKD2 relative to Variable expression of Pkd2 from the WS25 allele may the compound trans-heterozygote mechanism in human result from position effects of the intron 1 insertion and disease remains to be investigated. Studies on human variability in the proportion of null alleles generated by PKD2 cyst tissues and mating of Pkd1 ϩ/Ϫ with Pkd2 ϩ/Ϫ genomic rearrangement as well as possible genetic mice should yield additional insights into these issues. background effects. In Pkd2 WS25/WS25 mice, the likelihood of two intragenic recombination events occurring indePkd2 and the Kidney pendently in one cell is low. Mice that are most likely Cyst-lining cells are thought to be locked into an interto have a large number of cysts are those in which the mediate state of differentiation as a consequence of a initial recombination occurs in the parental germline or cystogenic event (Calvet, 1993) . Perhaps the de-differearly in embryonic development. In either event, a subentiation hypothesis can now be refined to state that, stantial proportion of cells in the organism will have one as a consequence of a molecular lesion in the PKD2 null allele. The dosage of the recombined allele in such pathway, individual tubular epithelial cells lose the ability mice may be sufficient to allow Southern blot detection to receive specific information regarding tissue organiof novel restriction fragments, accounting for our obserzation. In the absence of this contextual information, vation of these fragments in some severely affected they proliferate abnormally, change their specialized mice. The greater the proportion of cells affected by phenotypes, and expand into cystic structures. Our one null allele, the closer the rate of cyst formation ap- and Trudel, 1992) . Kidney tissue tained, and a clone containing the 5Ј end of the gene was identified was stained with YCC2 antibody as described previously (D'Agati by Southern hybridization and restriction mapping. The Pkd2x1neo and Trudel, 1992). YCC2 antibody (1:5000) was applied overnight targeting vector was constructed ( Figure 1A [ii]) and 30 mg of vector at 4ЊC. Rabbit anti-mouse Tamm-Horsfall antibody (1:1000) (gift of DNA was linearized at the unique vector SalI site and electroporated Dr. John Hoyer) was used for detection of distal tubules. into 2.5 ϫ 10 7 clone WW6 ES cells (Ioffe et al., 1995) . ES cell culture, electroporation, and selection with G418 were performed as deAcknowledgments scribed previously (Sirotkin et al., 1995) . At 9-10 days, 196 resistant colonies were picked. ES cell genomic DNA was screened for a
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